enVVeno Medical Corporation
NVNO
$1.02
$0.055.16%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 3.23M | 2.40M | 3.19M | 3.31M | 2.63M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 6.12M | 4.95M | 6.70M | 6.17M | 5.45M |
Operating Income | -6.12M | -4.95M | -6.70M | -6.17M | -5.45M |
Income Before Tax | -6.69M | -4.50M | -6.23M | -5.64M | -4.96M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -6.69M | -4.50M | -6.23M | -5.64M | -4.96M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -6.69M | -4.50M | -6.23M | -5.64M | -4.96M |
EBIT | -6.12M | -4.95M | -6.70M | -6.17M | -5.45M |
EBITDA | -6.09M | -4.91M | -6.66M | -6.13M | -5.40M |
EPS Basic | -0.33 | -0.22 | -0.31 | -0.35 | -0.31 |
Normalized Basic EPS | -0.18 | -0.15 | -0.20 | -0.24 | -0.21 |
EPS Diluted | -0.33 | -0.22 | -0.31 | -0.35 | -0.31 |
Normalized Diluted EPS | -0.18 | -0.15 | -0.20 | -0.24 | -0.21 |
Average Basic Shares Outstanding | 20.35M | 20.35M | 20.38M | 16.07M | 16.07M |
Average Diluted Shares Outstanding | 20.35M | 20.35M | 20.38M | 16.07M | 16.07M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |